Reviewed by Michael Gill, B. Sc.
18 Clostridium Difficile Clinical Trials Near Me
Top Hospitals for Clostridium Difficile Clinical Trials
Image of Henry Ford Health System in Michigan.
Henry Ford Health System
Detroit
2Active Trials
0All Time Trials for Clostridium Difficile
2016First Clostridium Difficile Trial
Image of St. Joseph's Healthcare Hamilton in Ontario.
St. Joseph's Healthcare Hamilton
Hamilton
1Active Trials
0All Time Trials for Clostridium Difficile
2022First Clostridium Difficile Trial
Top Cities for Clostridium Difficile Clinical Trials
Image of Madison in Wisconsin.
Madison
3Active Trials
William S. Middleton Memorial Veterans Hospital, Madison, WITop Active Site
Image of Milwaukee in Wisconsin.
Milwaukee
3Active Trials
Clement J. Zablocki VA Medical Center, Milwaukee, WITop Active Site
Clostridium Difficile Clinical Trials by Phase of Trial
Most Recent Clostridium Difficile Clinical Trials
Top Treatments for Clostridium Difficile Clinical Trials
Treatment Name
Active Clostridium Difficile Clinical Trials
All Time Trials for Clostridium Difficile
First Recorded Clostridium Difficile Trial
Vancomycin
3
3
2014
Fecal Microbiota Transplantation
2
2
2013
Chlorhexidine
1
1
2022
Intervention: Extended vancomycin regimen
1
1
2020
Universal gloving
1
1
2022

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 13th, 2021

Last Reviewed: October 7th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013 Jan 31;368(5):407-15. doi: 10.1056/NEJMoa1205037. Epub 2013 Jan 16. https://pubmed.ncbi.nlm.nih.gov/233238672 Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011 Nov;53(10):994-1002. doi: 10.1093/cid/cir632. Review. https://pubmed.ncbi.nlm.nih.gov/220029803 Taur Y, Jenq RR, Ubeda C, van den Brink M, Pamer EG. Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol. 2015 Jun-Sep;28(2-3):155-61. doi: 10.1016/j.beha.2015.10.013. Epub 2015 Oct 22. Review. https://pubmed.ncbi.nlm.nih.gov/265907734 Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015 Apr 16;372(16):1539-48. doi: 10.1056/NEJMra1403772. Review. https://pubmed.ncbi.nlm.nih.gov/258752595 Olsen MA, Yan Y, Reske KA, Zilberberg MD, Dubberke ER. Recurrent Clostridium difficile infection is associated with increased mortality. Clin Microbiol Infect. 2015 Feb;21(2):164-70. doi: 10.1016/j.cmi.2014.08.017. Epub 2014 Oct 12. https://pubmed.ncbi.nlm.nih.gov/256585606 McDonald EG, Milligan J, Frenette C, Lee TC. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection. JAMA Intern Med. 2015 May;175(5):784-91. doi: 10.1001/jamainternmed.2015.42. https://pubmed.ncbi.nlm.nih.gov/257301987 Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531-4. https://pubmed.ncbi.nlm.nih.gov/6253098 Levy AR, Szabo SM, Lozano-Ortega G, Lloyd-Smith E, Leung V, Lawrence R, Romney MG. Incidence and Costs of Clostridium difficile Infections in Canada. Open Forum Infect Dis. 2015 Jun 3;2(3):ofv076. doi: 10.1093/ofid/ofv076. eCollection 2015 Sep. https://pubmed.ncbi.nlm.nih.gov/261915349 Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis. 2012 Aug;55 Suppl 2:S65-70. doi: 10.1093/cid/cis319. Review. https://pubmed.ncbi.nlm.nih.gov/2275286710 Sax, PE. NEJM Journal Watch. http://blogs.jwatch.org/hiv-id-observations/index.php/fda-fecal- transplants-need-investigational-new-drug-application/2013/05/12/